[MO1] Mini-Oral Session 1　Lung Cancer / Thoracic Cancer 1（Cytotoxic）
【E】

[MO1-3] Prognosis and efficacy of adjuvant therapy in post-surgical NSCLC patients with WES-based genetic profiling

^○Akiko Tateishi¹, Hidehito Horinouchi¹, Takaaki Mizuno^1,7, Yu Okubo², Yukihiro Yoshida², Shun-Ichi Watanabe², Mototaka Miyake³, Masahiko Kusumoto³, Koji Inaba⁴, Hiroshi Igaki⁴, Yasushi Yatabe⁵, Katsuya Tanaka⁶, Naoki Mihara⁶, Kouya Shiraishi⁷, Takashi Kohno⁷, Yuichiro Ohe¹, Ryuji Hamamoto⁸ (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Department of Thoracic Surgery, National Cancer Center Hospital, 3.Department of Diagnostic Radiology, National Cancer Center Hospital, 4.Department of Radiation Oncology, National Cancer Center Hospital, 5.Department of Diagnostic Pathology, National Cancer Center Hospital, 6.Division of Medical Informatics, National Cancer Center Hospital, 7.Division of Genome Biology, National Cancer Center Research Institute, 8.Division of Medical AI Research and Development, National Cancer Center Research Institute)